Lowenthal Richard E 的 Form 4 申報
ARS Pharmaceuticals, Inc.（SPRY），2024/2/28 申報
- 申報編號
- 0001415889-24-005790
- 申報時間
- 2024/2/28
- 交易日
- 2024/2/26-2/28
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $89.7 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Lowenthal Richard ECIK 0001378550 | 董事、高階主管（總裁、執行長）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/2/26 | Common Stock | S賣出處分 | −100 | $9.01 | −$901 | 1,772,750 | 間接 | |
| 2024/2/26 | Common Stock | S賣出處分 | −500 | $9.01 | −$4,505 | 2,099,500 | 間接 | |
| 2024/2/26 | Common Stock | S賣出處分 | −100 | $9.01 | −$901 | 1,772,750 | 間接 | |
| 2024/2/28 | Common Stock | S賣出處分 | −25,456 | $9.02F5 | −$229,613.12 | 1,747,294 | 間接 | |
| 2024/2/28 | Common Stock | S賣出處分 | −49,019 | $9.02F6 | −$442,151.38 | 2,050,481 | 間接 | |
| 2024/2/28 | Common Stock | S賣出處分 | −24,303 | $9.02F7 | −$219,213.06 | 1,748,447 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F5
The weighted average sale price for the transaction reported was $9.0205, and the range of prices were between $9.00 and $9.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The weighted average sale price for the transaction reported was $9.0212, and the range of prices were between $9.00 and $9.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The weighted average sale price for the transaction reported was $9.0205, and the range of prices were between $9.00 and $9.17. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。